weight-loss and diet control industry

Page 5 of 10

After testing new drug compounds that appear to mimic the physical benefits of exercise in rodents, scientists say a pill may someday be able to do the same in humans.
Life

An exercise pill may soon offer the same benefits as a workout, scientists say

By
March 18, 2024
Oprah Winfrey
Finance

WeightWatchers, reeling from collapsing stock and Oprah’s departure in the age of Ozempic, vows to ‘prove the naysayers wrong’ and turn its fortunes around

By
March 14, 2024
Catherine Howarth, CEO of ShareAction.
Retail

Rebel investors want KitKat maker Nestlé to cut back on junk food—but the fortunes of its Mindful Chef brand suggest customers aren’t ready for a health kick

By
March 14, 2024
A person using Ozempic
Retail

Wegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations

By Ashleigh Furlong and Bloomberg
March 13, 2024
Does the GOLO Diet work? Experts explain the pros, cons, and risks
Life

Does the GOLO Diet work? Experts explain the pros, cons, and risks

By
March 9, 2024
tube of wegovy injections
Lifestyle

Novo Nordisk eclipses Tesla on positive trial results for a weight loss drug that may be more powerful than its own Wegovy 

By
March 8, 2024
62-year-old who lost 40 pounds in 9 months on Wegovy wants to stop the treadmill: ‘At some point you have to come off of them. I don’t want to be on them forever’
Health

62-year-old who lost 40 pounds in 9 months on Wegovy wants to stop the treadmill: ‘At some point you have to come off of them. I don’t want to be on them forever’

By Jonel Aleccia and The Associated Press
March 7, 2024
WHO
Health

A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says

By Naomi Kresge, Angela Feliciano and Bloomberg
March 1, 2024
Oprah Winfrey
Leadership

Oprah to leave WeightWatchers board, donating her stake over ‘perceived conflict of interest around her taking weight loss medications’

By
February 29, 2024
BOXES OF WEGOVY DRUGS
Lifestyle

Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results

By
February 27, 2024
Novo Nordisk’s CEO says he’s fielding calls from ‘scared’ junk food suppliers asking for advice over Ozempic surge
Retail

Novo Nordisk’s CEO says he’s fielding calls from ‘scared’ junk food suppliers asking for advice over Ozempic surge

By
February 8, 2024
Lars Fruergaard Jorgensen holding flashcards and talking
Retail

Novo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out of pocket for them

By
February 5, 2024
Americans spend an average of $5,300 a year on wellness. From biohacking to walking retreats, here are the top 10 trends driving the market
Life

Americans spend an average of $5,300 a year on wellness. From biohacking to walking retreats, here are the top 10 trends driving the market

By
February 2, 2024
Novo Nordisk hits $500B market value, climbing closer to the $1T club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year
Retail

Novo Nordisk hits $500B market value, climbing closer to the $1T club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year

By
January 31, 2024
Eli Lilly and Company says its popular drugs Mounjaro and Zepbound, also known as GLP-1s, are not meant for those without obesity or type 2 diabetes.
Aging Well

Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of for diabetes and obesity

By
January 4, 2024

Most Popular